An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents. (Q34004690)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944084%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944084%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944084%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

2

J Q Del Rosso

0 references

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944084%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Dermatology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944084%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944084%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944084%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

401-411

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944084%20AND%20SRC:MED&resulttype=core&format=json

Antifungal agents: an overview. Part II.

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Studies in the biochemistry of micro-organisms: Griseofulvin, C(17)H(17)O(6)Cl, a metabolic product of Penicillium griseo-fulvum Dierckx

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Tinea capitis: an overview with emphasis on management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Mass treatment of scalp ringworm by a single dose of griseofulvin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Experiences in one hundred thirty-seven patients treated with oral griseofulvin. Special reference to clinical recurrences. the healthy carrier state, and their management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Modern treatment of ringworm of the scalp. 391 trials of 25 treatment programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Orally administered ketoconazole: route of delivery to the human stratum corneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Comparison of single dose 400 mg versus 10-day 200 mg daily dose ketoconazole in the treatment of tinea versicolor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Our scabies treatment is archaic, but ivermectin has arrived.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Itraconazole for the treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Treatment of tinea capitis with itraconazole capsule pulse therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Fluconazole for the treatment of tinea capitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Intermittent short duration therapy with fluconazole is effective for tinea capitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Partial surgical avulsion of the nail in onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Fluconazole. An update of its antimicrobial activity, pharmacokinetic properties, and therapeutic use in vaginal candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Fluconazole in the treatment of tinea versicolor. Egyptian Fluconazole Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Current management of onychomycosis. An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Safety review of the oral antifungal agents used to treat superficial mycoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Onychomycosis in children: prevalence and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Pharmacologic basis for the treatment of tinea capitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Efficacy and safety of oral fluconazole in the treatment of patients with tinea corporis, cruris or pedis or cutaneous candidosis : a multicentre, open, noncomparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

The effects of repeated dermal application of capsaicin to the human skin on pain and vasodilatation induced by intradermal injection of acid and hypertonic solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

21 January 2018

Terbinafine: an update

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Terbinafine for the treatment of pedal onychomycosis. A foot closer to the promised land of cured nails?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Terbinafine pulse therapy is effective in tinea capitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Oral antifungal agents for onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: A multicenter study with 36 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Onychomycosis in children: prevalence and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

Experimental Ringworm in Guinea Pigs: Oral Treatment with Griseofulvin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2000.00964.X

10.1046/J.1365-4362.2000.00964.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944084%20AND%20SRC:MED&resulttype=core&format=json

release_arqd74ob3vfirajx3luwtbnm4q

9 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/arqd74ob3vfirajx3luwtbnm4q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference